Canada: Canadian Public Capital Markets – Punching Above Their Weight In The Life Sciences Sector


In recent years, the Canadian market has evolved into a leading platform for the financing and listing of innovation companies on Canadian stock exchanges. A major driver behind this growth has been Canadian investors' appetite for investing in early stage and growth oriented public companies. Canada is emerging as a hub - or you might even say a network of hubs in Toronto, Vancouver and Montreal - for the innovation sectors. Increasingly Canadian companies are choosing to stay in Canada and invite investors from Silicon Valley, Boston and other high profile tech markets to participate in private round financings, initial public offerings (IPOs) and follow on offerings here in Canada. What Do the Market Figures Tell Us About Innovation Companies

Listed in Canada?

While enjoying a formidable combined market capitalization of over $2.3 trillion, the TSX and TSX Venture Exchange (TSX-V), the exchange for public venture companies (in combination referred to as TMX) is indeed more than the world's leading mining, energy and resources market. TMX boasts a vast market for mining and energy companies, with a combined market cap of $412 billion, and includes some of the world's iconic mining and oil and gas enterprises. But these figures hardly tell another amazing story of how the Canadian market has evolved to become a significant ecosystem for hundreds of innovation companies in Life Sciences, Clean Tech and Renewables, Technology and Communications and Media, with a combined market cap of $351 billion.

During 2014 and 2015, 69 new technology and innovation companies went public on the TSX and TSX-V, more than any other industry sector and they raised over $17 billion in equity during the same period.

For investors, there are currently over 420 technology and innovation companies listed on the TSX and TSX-V, offering the opportunity for diversification and to participate in numerous fast-growing businesses–many with global operations.

During the period from 2009 to 2015, TSX and TSX-V listed issuers in the innovation sector completed 178 IPOs and new listings, raised $34 billion and experienced a $128 billion increase in market value.

The exciting data point within this is that Life Sciences companies listed on the TMX have a combined market cap of over $80 billion. While the vast majority (92%) of these companies are pharma businesses, they also include biotech, healthcare facilities, healthcare services and healthcare technology.

What the TMX Has to Offer

The TMX is the fourth largest exchange in the world measured by the amount of capital raised by its issuers. It only trails New York, NASDAQ and Hong Kong. So far in 2016, TMX's shares have outpaced all but two of its 26 peers in the Bloomberg world exchanges index.

The TMX is home to more than 127 Life Sciences companies and in 2015, life sciences companies on the TSX and the TSX-V raised $6.5 billion of capital which includes the $1.8 billion financing of Valeant Pharmaceuticals International Inc. TMX-listed life sciences companies had good investment coverage with approximately 80% of them enjoying analyst reporting. This in turn contributed to better informed investors and traders who were behind the $5.3 billion worth of life sciences companies' shares that were traded on the TMX last year.

The Bought Deal – A Uniquely Canadian Concept

And speaking about innovation, Canada's regulatory regime allows public companies to raise capital through the unique "bought deal" offering in which an investment bank commits to buy the shares of a company and resells them into the market, thereby providing the company with a guarantee of sorts that its financing will be successful. This flexible mechanism is routinely used by issuers to fund growth, as well as by significant shareholders to obtain liquidity, but it is a "made and used in Canada only" mechanism and has not (at least not, yet) been adopted in the U.S.

Canada-U.S. Financing Flexibility

Also of note is that securities regulators have an accommodation in place for Canadian public companies looking to raise capital from U.S. based investors. Generally, if a company has been public in Canada for at least a year and has a public float of more than US$75 million, it may take advantage of the multijurisdictional disclosure system (MJDS). The MJDS permits a company to raise capital in the U.S. with minimal U.S. regulatory and consequential timing risks. Note, however, that a "Southbound MJDS" company must still qualify as a foreign private issuer under US law at the time it files for its offering in the U.S. and annually thereafter.

A Canadian issuer not currently contemplating a U.S. financing may nevertheless also list on a U.S. exchange. In addition to broadening the investor base, a U.S. listing may provide competitive advantages: in a U.S. acquisition, shares may be offered as consideration to shareholders of the target company. Southbound MJDS companies do not face significant additional reporting obligations as a result of a U.S. listing.

Recent examples of Successful Life Sciences Companies Raising Money through Public Offerings

  • Titan Medical Inc., a leading developer of a patented surgical robotic system for use in minimally invasive surgery, went public through the TSX-V's highly successful Capital Pool Company (CPC) program in 2008 before the company had developed a functional prototype of its device. The company has, since then, raised over $100 million through a number of public and private offerings for the development of its SPORT surgical system, and it is now listed on the TSX. The SPORT was recently demonstrated at a leading healthcare conference in Boston.
  • Cynapsus is a specialty, pharmaceutical company developing and preparing to commercialize a Phase 3, fast-acting, easy-to-use, sublingual thin film for the on-demand management of debilitating "off" episodes associated with chronic, progressive neurodegenerative diseases characterized by motor symptoms. Cynapsus originally went public on the TMX through the CPC program and it has raised approximately $150 million through private placements and public offerings over the past 12 years, including US$72.5 million raised through its public offering in the U.S. in 2015. Cynapsus is an excellent example of how a Canadian company may go public and raise substantial capital in the Canadian market and then when it reaches a size and stage of its technology that U.S. investors demand, complete a "re-IPO" in the U.S. with a concurrent co-listing on the NASDAQ, while remaining a Canadian corporation and maintaining its listing on the TSX.

Having regard to the compelling market statistics, Canadian life sciences companies are well advised to explore the advantages of a public listing in Canada.

About BLG

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions